The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]


Variant: NM_000215.4(JAK3):c.2680+89G>A

CA2580096763

2054022 (ClinVar)

Gene: JAK3 (HGNC:3718)
Condition: T-B+ severe combined immunodeficiency due to JAK3 deficiency (MONDO:0010938)
Inheritance Mode: Autosomal recessive inheritance
UUID: 4e2369b8-c6c4-49d0-8477-732961ea7303
Approved on: 2024-01-17
Published on: 2024-01-17

HGVS expressions

NM_000215.4:c.2680+89G>A
NM_000215.4(JAK3):c.2680+89G>A
NC_000019.10:g.17832430C>T
CM000681.2:g.17832430C>T
NC_000019.9:g.17943239C>T
CM000681.1:g.17943239C>T
NC_000019.8:g.17804239C>T
NG_007273.1:g.20562G>A
ENST00000458235.7:c.2680+89G>A
ENST00000458235.5:c.2680+89G>A
ENST00000527031.5:n.2278+4297G>A
ENST00000527670.5:c.2680+89G>A
ENST00000534444.1:c.2680+89G>A
NM_000215.3:c.2680+89G>A
More

Likely Pathogenic

Met criteria codes 5
PM3_Supporting PM2_Supporting PP1_Moderate PP4_Moderate PP3

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Severe Combined Immunodeficiency Disease Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for JAK3 Version 1.0.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Severe Combined Immunodeficiency Disease VCEP
The variant NM_000215.4(JAK3):c.2680+89G>A has been found in three individuals with T-B+NK- SCID. In three related consanguineous families, the disease phenotype segregated with the homozygous deep intronic variant in the proband, P3, and two affected relatives (PP1_moderate, PM3_supporting). In at least one of those patients, P3, with T-B+NK- SCID, whole exome sequencing was performed and STAT3 and STAT5 phosphorylation were found to be absent in B cells after stimulation with IL-21 (PMID:26769277, 3 points, PP4_moderate). The variant is absent from gnomAD (PM2_Supporting). Finally, the in silico predictor SpliceAI predicts that the deep intronic variant may impact splicing with a delta score of 0.30 (PP3). In summary, this variant meets criteria to be classified as Likely Pathogenic for autosomal recessive T-B+ severe combined immunodeficiency due to JAK3 deficiency based on the ACMG/AMP criteria applied, as specified by the ClinGen SCID VCEP: PP1_moderate, PM3_supporting, PP4_moderate, PP3, PM2_supporting (SCID VCEP Specifications Version 1).
Met criteria codes
PM3_Supporting
The variant has been found in the homozygous state in an individual with T-B+NK- SCID (PMID:26769277, 0.5 points).
PM2_Supporting
Variant is absent from gnomAD (PM2_supporting).
PP1_Moderate
The disease T-B+NK- SCID phenotype segregated in the proband and 2 affected relatives in one large consanguineous family with no reported unaffected individuals who were homozygous for the splicing variant.
PP4_Moderate
In at least one patient with the variant: diagnostic criteria for SCID met (.5), Whole Exome Sequencing performed (.5), family history of SCID (.5), T-B+NK- lymphocyte subset profile (.5), and STAT3 and STAT5 phosphorylation were found to be absent in B cells after stimulation with IL-21 (1 pt). In conclusion, this individual meets the criteria for PP4_moderate (3 points).
PP3
SpliceAI predicts that the deep intronic variant may impact splicing with a delta score of 0.30, which is greater than 0.2 and thus meets PP3.
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
ClinGen Terms of Use.
¤ Powered by BCM's Genboree.